Tocagen Inc.

3030 Bunker Hill St., San Diego, CA 92109

Private
Healthcare & Pharmaceuticals - Biotechnology
around $5 - 10M
around 50 - 100
(858) 412-8400
858-412-8499


Tocagen Inc. is located at 3030 Bunker Hill St., San Diego, CA 92109. It has around 50 - 100 employees. Its revenue is around $5 - 10M. Scientific service primarily engaged in conducting research and analyses in cognitive development, sociology, psychology, language, behavior, economic and other social sciences. The parent company of this organization is Tocagen Inc ...

Competitor - 1/9
Which company is more competitive with Tocagen Inc.?




24 Contacts at this company
Alice Chu
Statistical Consultant
Sean Mitchell
Intellectual Property Portfolio Manager ...
Tim Butterfield
Quality Manager
Daniel Pertschuk
Franklin and Marshall College
Veronica Portillo
Senior Executive Assistant
Stephen Soonthornvacharin
Research Scientist I
Aliz Rao
Research Scientist 1, Bioinformatics
Oscar Diago
Research Scientist 1

Sep 25, 2018 08:52:04
SAN DIEGO, Sept. 24, 2018 /PRNewswire/ -- Tocagen Inc. (Nasdaq :TOCA ), a clinical-stage, cancer-selective gene therapy company, today announced the appointment of Mohamed Ladha as vice president, head of commercial. [...]

Aug 9, 2017 20:43:41
SAN DIEGO, Aug. 9, 2017 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today reported financial results for the second quarter ended June 30, 2017 [...]

Aug 2, 2017 20:48:52
SAN DIEGO, Aug. 2, 2017 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced it will report its second quarter 2017 financial results and [...]

May 23, 2017 20:42:51
SAN DIEGO, May 23, 2017 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today reported financial results for the first quarter ended March 31, [...]

Apr 19, 2017 20:42:49
SAN DIEGO, April 19, 2017 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced the closing of its initial public offering of common stock, [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.